Table 1

Baseline characteristics of study population, PREDICT, unadjusted

MenWomen
EuropeanIndianEuropeanIndian
N126 73620 21095 34714 173
Age in years, mean (SD)54.4 (9.0)46.2 (10.0)58.8 (8.1)52.2 (8.7)
TC/HDL ratio, mean (SD)4.30 (1.2)4.62 (1.2)3.60 (1.1)3.93 (1.0)
TC (mmol/L), mean (SD)5.33 (1.0)5.08 (1.0)5.64 (1.0)5.03 (1.0)
BMI, mean (SD)28.5 (5.2)26.9 (4.4)28.1 (6.3)28.0 (5.4)
Prevalence of obesity (BMI≥30), %31.118.931.230.1
Prevalence of overweight (BMI≥25) %78.066.565.570.9
SBP (mm Hg), mean (SD)130.3 (15.9)125.2 (15.9)130.2 (17.2)125.5 (17.6)
SBP≥140 mm Hg, %29.319.230.922.3
Diabetes
 Type 1, %0.70.40.60.4
 Type 2, %7.423.07.128.2
Smoking
 Never, %68.483.273.398.0
 Former, %17.96.415.80.9
 Current*, %13.810.310.91.2
Family history of CVD, %12.48.715.68.9
Receiving antihypertensive treatment at baseline†, %16.718.222.424.2
Receiving lipid-lowering treatment at baseline†, %14.022.314.422.3
New Zealand deprivation index score, five quintiles‡
 Deprivation quintile 1 (least deprived), %31.310.530.812.3
 Deprivation quintile 2, %24.117.123.718.4
 Deprivation quintile 3, %19.320.519.820.3
 Deprivation quintile 4, %15.128.915.727.5
 Deprivation quintile 5 (most deprived), %10.223.110.021.5
Years of follow-up (range)4.1 (1 day-13.3 years)4.1 (2 days–13.2 years)4.2 (1 day–13.3 years)4.1 (4 days–13.1 years)
  • *Current smokers includes persons who recently quit (<12 months ago).

  • †Medication use at baseline is based on dispensing information within 6 months before baseline.

  • ‡The quintiles are based on the distribution of the first principal component scores for the New Zealand Index of Socioeconomic Deprivation, where quintile 1 indicates residence in the 20% of the least deprived census meshblocks (geographic areas including approximately 80 people) in New Zealand.

  • BMI, body mass index; BP, blood pressure; CVD, cardiovascular disease; HDL, high-density lipoprotein; SBP, systolic blood pressure; TC, total cholesterol.